KYMERA THERAPEUTICS INC (KYMR) — insider trading
Health Care · NASDAQ
KYMERA THERAPEUTICS INC (KYMR) has 132 reported SEC Form 4 insider transactions in our data, including 93 open-market sales among the most recent 100 (latest 2026-07-07).
Recent Form 4 transactions
Showing the 100 most recent of 132 recorded transactions. See all on SEC EDGAR →
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-07 | Mainolfi Nello | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 4,441 | $0.00 | $0 | Form 4 |
| 2026-07-07 | Mainolfi Nello | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 45,559 | $0.00 | $0 | Form 4 |
| 2026-07-07 | Mainolfi Nello | Director, Officer (Chief Executive Officer) | Open-market sale | 50,000 | $119.00 | $5.95M | Form 4 |
| 2026-07-07 | Mainolfi Nello | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 50,000 | $2.08 | $104.0K | Form 4 |
| 2026-07-01 | Mainolfi Nello | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 80,000 | $0.00 | $0 | Form 4 |
| 2026-07-01 | Mainolfi Nello | Director, Officer (Chief Executive Officer) | Open-market sale | 3,336 | $116.56 | $388.8K | Form 4 |
| 2026-07-01 | Mainolfi Nello | Director, Officer (Chief Executive Officer) | Open-market sale | 44,050 | $115.69 | $5.10M | Form 4 |
| 2026-07-01 | Mainolfi Nello | Director, Officer (Chief Executive Officer) | Open-market sale | 24,105 | $114.96 | $2.77M | Form 4 |
| 2026-07-01 | Mainolfi Nello | Director, Officer (Chief Executive Officer) | Open-market sale | 6,626 | $113.98 | $755.2K | Form 4 |
| 2026-07-01 | Mainolfi Nello | Director, Officer (Chief Executive Officer) | Open-market sale | 1,883 | $112.80 | $212.4K | Form 4 |
| 2026-07-01 | Mainolfi Nello | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 80,000 | $2.08 | $166.4K | Form 4 |
| 2026-07-01 | Goodman Noah | Officer (Chief Business Officer) | Open-market sale | 3,389 | $114.29 | $387.3K | Form 4 |
| 2026-06-30 | Jacobs Bruce N. | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 61,378 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Jacobs Bruce N. | Officer (Chief Financial Officer) | Open-market sale | 3,200 | $117.70 | $376.6K | Form 4 |
| 2026-06-30 | Jacobs Bruce N. | Officer (Chief Financial Officer) | Open-market sale | 6,153 | $116.99 | $719.9K | Form 4 |
| 2026-06-30 | Jacobs Bruce N. | Officer (Chief Financial Officer) | Open-market sale | 7,971 | $115.82 | $923.2K | Form 4 |
| 2026-06-30 | Jacobs Bruce N. | Officer (Chief Financial Officer) | Open-market sale | 51,375 | $114.77 | $5.90M | Form 4 |
| 2026-06-30 | Jacobs Bruce N. | Officer (Chief Financial Officer) | Open-market sale | 4,110 | $114.19 | $469.3K | Form 4 |
| 2026-06-30 | Jacobs Bruce N. | Officer (Chief Financial Officer) | Open-market sale | 1,100 | $112.79 | $124.1K | Form 4 |
| 2026-06-30 | Jacobs Bruce N. | Officer (Chief Financial Officer) | Open-market sale | 1,700 | $111.57 | $189.7K | Form 4 |
| 2026-06-30 | Jacobs Bruce N. | Officer (Chief Financial Officer) | Open-market sale | 1,500 | $110.54 | $165.8K | Form 4 |
| 2026-06-30 | Jacobs Bruce N. | Officer (Chief Financial Officer) | Option exercise / conversion | 61,378 | $5.33 | $327.1K | Form 4 |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 130 | $111.20 | $14.5K | Form 4/A |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 1,078 | $110.67 | $119.3K | Form 4/A |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 1,104 | $109.75 | $121.2K | Form 4/A |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 1,498 | $108.28 | $162.2K | Form 4/A |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 2,698 | $107.76 | $290.7K | Form 4/A |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 2,133 | $106.63 | $227.4K | Form 4/A |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 770 | $105.78 | $81.5K | Form 4/A |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 934 | $111.20 | $103.9K | Form 4/A |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 7,723 | $110.67 | $854.7K | Form 4/A |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 7,968 | $109.75 | $874.5K | Form 4/A |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 10,848 | $108.28 | $1.17M | Form 4/A |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 19,419 | $107.76 | $2.09M | Form 4/A |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 14,798 | $106.63 | $1.58M | Form 4/A |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 5,549 | $105.78 | $587.0K | Form 4/A |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 3,024 | $107.76 | $325.9K | Form 4 |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 2,318 | $106.63 | $247.2K | Form 4 |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 848 | $105.78 | $89.7K | Form 4 |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 19,093 | $107.76 | $2.06M | Form 4 |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 14,613 | $106.63 | $1.56M | Form 4 |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 5,471 | $105.78 | $578.7K | Form 4 |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 157 | $111.20 | $17.5K | Form 4 |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 1,199 | $110.67 | $132.7K | Form 4 |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 1,239 | $109.75 | $136.0K | Form 4 |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 1,688 | $108.28 | $182.8K | Form 4 |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 907 | $111.20 | $100.9K | Form 4 |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 7,602 | $110.67 | $841.3K | Form 4 |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 7,833 | $109.75 | $859.7K | Form 4 |
| 2026-06-29 | Booth Bruce | Director | Open-market sale | 10,658 | $108.28 | $1.15M | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 1,729 | $118.66 | $205.2K | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 3,069 | $117.85 | $361.7K | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 1,701 | $117.09 | $199.2K | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 952 | $115.69 | $110.1K | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 3,896 | $114.94 | $447.8K | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 2,083 | $113.97 | $237.4K | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 78 | $112.49 | $8.8K | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 1,442 | $111.51 | $160.8K | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 1,579 | $110.49 | $174.5K | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 4,562 | $109.79 | $500.9K | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 32,402 | $108.14 | $3.50M | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 3,958 | $107.57 | $425.8K | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 12,390 | $118.66 | $1.47M | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 22,046 | $117.85 | $2.60M | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 12,181 | $117.09 | $1.43M | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 6,821 | $115.69 | $789.1K | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 27,951 | $114.94 | $3.21M | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 14,913 | $113.97 | $1.70M | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 555 | $112.49 | $62.4K | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 10,366 | $111.51 | $1.16M | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 11,277 | $110.49 | $1.25M | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 32,624 | $109.79 | $3.58M | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 231,007 | $108.14 | $24.98M | Form 4 |
| 2026-06-26 | Booth Bruce | Director | Open-market sale | 28,296 | $107.57 | $3.04M | Form 4 |
| 2026-06-26 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | Director, Other | Open-market sale | 51,858 | $106.50 | $5.52M | Form 4 |
| 2026-06-26 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | Director, Other | Open-market sale | 113,289 | $106.50 | $12.07M | Form 4 |
| 2026-06-26 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | Director, Other | Open-market sale | 627,597 | $106.50 | $66.84M | Form 4 |
| 2026-06-26 | BVF PARTNERS L P/IL; BIOTECHNOLOGY VALUE FUND L P; BVF I GP LLC; BIOTECHNOLOGY VALUE FUND II LP; BVF II GP LLC; Biotechnology Value Trading Fund OS LP; BVF Partners OS Ltd.; BVF GP HOLDINGS LLC; BVF INC/IL; LAMPERT MARK N | Director, Other | Open-market sale | 837,914 | $106.50 | $89.24M | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 2,646 | $118.60 | $313.8K | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 3,359 | $117.50 | $394.7K | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 11,375 | $116.53 | $1.33M | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 8,389 | $115.57 | $969.5K | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 1,289 | $114.65 | $147.8K | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 1,437 | $113.70 | $163.4K | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 100 | $111.89 | $11.2K | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 86 | $110.79 | $9.5K | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 265 | $110.30 | $29.2K | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 2,011 | $108.83 | $218.9K | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 23 | $108.02 | $2.5K | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 1,399 | $107.30 | $150.1K | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 19,089 | $118.60 | $2.26M | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 24,268 | $117.50 | $2.85M | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 81,500 | $116.53 | $9.50M | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 58,205 | $115.57 | $6.73M | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 9,229 | $114.65 | $1.06M | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 10,215 | $113.70 | $1.16M | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 719 | $111.89 | $80.4K | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 614 | $110.79 | $68.0K | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 1,915 | $110.30 | $211.2K | Form 4 |
| 2026-06-25 | Booth Bruce | Director | Open-market sale | 14,351 | $108.83 | $1.56M | Form 4 |
Ask the chat about KYMR's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: KYMERA THERAPEUTICS INC (KYMR).
Last updated 2026-07-07 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.